drugset / Trial / NCT02991339

The Effects of Dexamethasone Administration on Jaundice Following Liver Resection

NCT02991339

Phase 2/3 Completed 76 enrolled Shanghai Zhongshan Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

The investigators were aiming to evaluate whether dexamethasone administration accelerates the recovery from hepatectomy-related jaundice and decreases the rates of post-hepatectomy liver failure and its safety in the subjects who developed elevated serum total bilirubin.

Timeline

Start
2016-06
Primary completion
2017-12
Completion
2018-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 5 mg Intravenous